UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$25.3B |
| 2 |
Bank of America
BAC
|
+$1.96B |
| 3 |
Applied Materials
AMAT
|
+$1.43B |
| 4 |
NetEase
NTES
|
+$1.18B |
| 5 |
Union Pacific
UNP
|
+$870M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$7.17B |
| 2 |
Apple
AAPL
|
+$3.39B |
| 3 |
UBS Group
UBS
|
+$2.73B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.53B |
| 5 |
Meta Platforms (Facebook)
META
|
+$2.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.88% |
| 2 | Financials | 12.37% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Healthcare | 9.66% |
| 5 | Communication Services | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1826
Innovex International
INVX
$1.92B
| $1.66M | ﹤0.01% |
89,304
-46,282
| -34% | -$770K |
2013 Q2
49 quarters
|
|
1827
Southside Bancshares
SBSI
$909M
| $1.65M | ﹤0.01% |
58,491
-35,422
| -38% | -$1.07M |
2013 Q2
49 quarters
|
|
1828
SI-BONE Inc
SIBN
$892M
| $1.65M | ﹤0.01% |
112,202
-28,220
| -20% | -$461K |
2020 Q4
19 quarters
|
|
1829
KB Financial Group
KB
$41.4B
| $1.65M | ﹤0.01% |
19,905
+3,925
| +25% | +$322K |
2024 Q1
6 quarters
|
|
1830
Summit Therapeutics
SMMT
$12.3B
| $1.64M | ﹤0.01% |
79,589
-7,300
| -8% | -$177K |
2025 Q2
1 quarter
|
|
1831
Franklin BSP Realty Trust
FBRT
$521M
| $1.64M | ﹤0.01% |
151,304
+76,274
| +102% | +$840K |
2021 Q4
15 quarters
|
|
1832
Limbach Holdings
LMB
$570M
| $1.62M | ﹤0.01% |
16,704
-13,119
| -44% | -$1.58M |
2024 Q3
4 quarters
|
|
1833
Janux Therapeutics
JANX
$1.06B
| $1.62M | ﹤0.01% |
66,325
-45,037
| -40% | -$1.1M |
2024 Q1
6 quarters
|
|
1834
Hamilton Insurance Group
HG
$3.5B
| $1.61M | ﹤0.01% |
65,069
-55,654
| -46% | -$1.27M |
2024 Q1
6 quarters
|
|
1835
Herbalife
HLF
$1.53B
| $1.61M | ﹤0.01% |
190,644
-102,316
| -35% | -$965K |
2013 Q2
49 quarters
|
|
1836
Lennar Class B
LEN.B
$18.3B
| $1.61M | ﹤0.01% |
13,403
-618
| -4% | -$73.3K |
2023 Q1
10 quarters
|
|
1837
GPGI Inc
GPGI
$3.68B
| $1.61M | ﹤0.01% |
77,125
-40,176
| -34% | -$695K |
2024 Q4
3 quarters
|
|
1838
Community Trust Bancorp
CTBI
$1.35B
| $1.61M | ﹤0.01% |
28,691
-19,326
| -40% | -$1.08M |
2024 Q2
5 quarters
|
|
1839
Hertz
HTZ
$652M
| $1.6M | ﹤0.01% |
235,163
-209,207
| -47% | -$1.34M |
2023 Q1
10 quarters
|
|
1840
Hanmi Financial
HAFC
$917M
| $1.58M | ﹤0.01% |
63,919
-64,272
| -50% | -$1.58M |
2022 Q2
13 quarters
|
|
1841
Liquidity Services
LQDT
$1.38B
| $1.57M | ﹤0.01% |
57,272
-47,480
| -45% | -$1.22M |
2021 Q4
15 quarters
|
|
1842
Tidewater
TDW
$3.94B
| $1.57M | ﹤0.01% |
29,456
-16,674
| -36% | -$914K |
2022 Q2
13 quarters
|
|
1843
Amalgamated Financial
AMAL
$1.41B
| $1.57M | ﹤0.01% |
57,723
-30,487
| -35% | -$906K |
2023 Q1
10 quarters
|
|
1844
Helen of Troy
HELE
$691M
| $1.56M | ﹤0.01% |
62,099
-35,073
| -36% | -$849K |
2013 Q2
49 quarters
|
|
1845
Vicor
VICR
$10.1B
| $1.55M | ﹤0.01% |
31,219
-32,841
| -51% | -$1.6M |
2019 Q1
26 quarters
|
|
1846
Navitas Semiconductor
NVTS
$2.42B
| $1.55M | ﹤0.01% |
+214,378
| New | +$1.43M |
2025 Q3
0 quarters
|
|
1847
Enact Holdings
ACT
$6.28B
| $1.55M | ﹤0.01% |
40,323
+14,051
| +53% | +$521K |
2023 Q1
10 quarters
|
|
1848
Applied Optoelectronics
AAOI
$7.11B
| $1.54M | ﹤0.01% |
59,561
-47,907
| -45% | -$1.22M |
2024 Q2
5 quarters
|
|
1849
Tootsie Roll Industries
TR
$2.88B
| $1.54M | ﹤0.01% |
37,864
-19,021
| -33% | -$720K |
2019 Q1
26 quarters
|
|
1850
Diversified Healthcare Trust
DHC
$1.84B
| $1.54M | ﹤0.01% |
349,339
-163,943
| -32% | -$625K |
2023 Q3
8 quarters
|
|
Similar funds
UBS AM's Q3 2025 Portfolio in Review
As of Q3 2025, UBS AM held 2,672 positions worth $461B, down 6.8% from $494B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
UBS AM withdrew a net $68.7B in Q3 2025, closing 403 positions and reducing 2,008 holdings. Its most notable exit was Pinduoduo, an estimated $967M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Vanguard Dividend Appreciation ETF worth $135M.
- UBS AM's largest Q3 2025 buy was Vanguard Dividend Appreciation ETF: 624,303 shares worth $135M.
- UBS AM added most to Microsoft in Q3 2025, an estimated $25.3B increase.
- UBS AM's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $7.17B.
- UBS AM fully exited Pinduoduo in Q3 2025, selling an estimated $967M.
- UBS AM's ten largest holdings make up 35% of its $461B portfolio in Q3 2025.
- UBS AM opened 67 new positions and closed 403 in Q3 2025.
- UBS AM's portfolio value fell 6.8% quarter-over-quarter to $461B.
Based on UBS AM's 13F filing for Q3 2025, filed 14 Nov 2025.